Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Brain Cancer Study took one step with its first patient participation
Date 09 January 2026

Brain Cancer Study took one step with its first patient participation

Announcement Exvade Bioscience is a certified neuro-oncology company known for its impeccable platform for healing the violent brain cancers has conducted a brain cancer study. The phase 1 clinical t...

Arrowhead put the weight on Tirzepatide to help the obese population
Date 09 January 2026

Arrowhead put the weight on Tirzepatide to help the obese population

Announcement Arrowhead is headed to double the Tirzepatide’s weightloss in the combinational study. After proving its excellence in therapies to cure the diseases causing genes, the company has...

Huntington's disease in the progressive limelight
Date 09 January 2026

Huntington's disease in the progressive limelight

Progress so far For many decades, there have been many challenges and a level of improvement in numerous neurodegenerative conditions. Over the past two years, uniQure’s data received a green s...

TYBR Health's new gel formulation to heal post-surgical wounds
Date 08 January 2026

TYBR Health's new gel formulation to heal post-surgical wounds

Announcement TYBR Health is a known Houston-related regenerative medicine and medical technology company popular for its establishment in biomaterials therapies to refine post-operative recovery. The...

GenEditBio's Application went on another desk for the TGFBI Corneal Dystrophy
Date 08 January 2026

GenEditBio's Application went on another desk for the TGFBI Corneal Dystrophy

Announcement GenEditBio stepped into the biotech competition in 2021 with one goal and mission in mind to serve vivo genome-editing therapeutic solutions. The company now excitedly declared that its ...

Novo to count profit on one gulp with its new Wegovyâ„¢ Pill launch
Date 08 January 2026

Novo to count profit on one gulp with its new Wegovyâ„¢ Pill launch

Announcement Novo Nordisk, the promising Danish healthcare organisation known for its excellent progress in diabetes care and later splitting its business and excellence in rare blood disorders, grow...

Takeda's seriousness towards Trial Representation to revolutionise the Clinical Research sector
Date 08 January 2026

Takeda's seriousness towards Trial Representation to revolutionise the Clinical Research sector

Announcement Takeda, with a strong footprint in Europe, Japan, and the US, and popularly recognised for its Entyvio for IBD, as Asia’s third-largest pharmaceutical company, shed some light on t...

BioAtla and GATC initiate SPV transaction to bolster the ongoing study
Date 06 January 2026

BioAtla and GATC initiate SPV transaction to bolster the ongoing study

Announcement BioAtla, Inc., a leading clinical-level biotechnology company focusing on the establishment of Conditionally Active Biologic (CAB) antibody therapeutics for solid tumor treatment, has jo...

Axsome receives clearance to NDA filing for AXS-05 and Priority Review designation
Date 06 January 2026

Axsome receives clearance to NDA filing for AXS-05 and Priority Review designation

Announcement Axsome Therapeutics, Inc., a leading biopharmaceutical company revolutionising the treatment space of central nervous system (CNS) disorders, received acceptance from the U.S. Food and D...

Intelligent and Syrma entered a manufacturing partnership agreement
Date 06 January 2026

Intelligent and Syrma entered a manufacturing partnership agreement

Announcement Intelligent Bio Solutions Inc., a leading medical technology company serving an emerging, non-invasive brilliant testing solutions, have inked a manufacturing deal with Syrma Johari MedT...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.